Target intelligence / Profile preview

Rapidly Accelerated Fibrosarcoma kinase family (RAF)

Target
RAF
Molecular classification
Enzyme, Serine/threonine protein kinase
01

Overview

The RAF kinase family comprises three closely related serine/threonine-specific protein kinases: A-Raf, B-Raf, and C-Raf (also known as Raf-1). These kinases are central components of the RAS-RAF-MEK-ERK signaling cascade, also referred to as the mitogen-activated protein kinase (MAPK) pathway. This pathway is crucial for transmitting signals from extracellular growth factors to promote cell division, differentiation, and survival. Mutations or dysregulation within this pathway—especially activating mutations in BRAF—are implicated in various cancers such as melanoma, colorectal cancer, thyroid cancer, among others. As such, several small-molecule inhibitors targeting different members or domains within this family have been developed or are under clinical investigation.

Other names
RAF kinasesA-RafB-RafC-RafRaf-1ARAFBRAFRAF1
02

Mechanism of action

RAF kinases phosphorylate and activate MEK1/2, leading to downstream ERK/MAPK activation.

03

Biological functions

Signal transductionCell proliferationCell survivalCell differentiation
04

Disease associations

Cancer
05

Safety considerations

Resistance to RAF inhibitorsParadoxical activation of MAPK pathway in certain BRAF inhibitor contexts
06

Interacting drugs

Small-molecule inhibitors targeting RAF kinases
07

Biomarkers

BRAF mutations (e.g., BRAF V600E) for patient selection in melanoma and other cancers

Beyond the preview

Go deeper on Rapidly Accelerated Fibrosarcoma kinase family (RAF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rapidly Accelerated Fibrosarcoma kinase family (RAF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call